Current and new antitumor necrosis factor agents in perspective
Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?
Does route of administration affect the outcome of TNF antagonist therapy?

Current and new antitumor necrosis factor agents in perspective
Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?
Does safety make a difference in selecting the right TNF antagonist?
Does route of administration affect the outcome of TNF antagonist therapy?
Effective use of TNF antagonists
Treating psoriatic arthritis: how effective are TNF antagonists?
Expanding the armamentarium for the spondyloarthropathies

Molecular cross-talk between the TRAIL and TGF-? pathways in human lung fibroblasts
Interaction between hsp73 and rheumatoid-arthritis-associated HLA-DR alleles
HLA DRB101 and macrophagic myofasciitis
Influence of HLA-DRB1 P4 binding pocket electric charge on rheumatoid arthritis (RA) susceptibility
Effect of synovial fluid on adeno-associated virus mediated gene transfer to chondrocytes
Immunotherapy through injection of immature dendritic cells prevents collagen-induced arthritis
Gene therapy of destructive arthritis in SCID mice
RA-specific expression profiles and new candidate genes
Epstein–Barr virus load is higher in rheumatoid arthritis patients than in normal controls
Fast and sensitive method for the detection of bacteria in synovial fluid by multiplex PCR
HMGB1, a new proinflammatory molecule of interest in polymyositis and dermatomyositis patients